Procalcitonin Levels in Patients with Complete and Incomplete Kawasaki Disease

Figure 2

Differences in procalcitonin levels among patients with complete Kawasaki disease (KD), incomplete KD, and other febrile illnesses (controls), on the day of diagnosis and 2, 14, and 56 days after intravenous immunoglobulin (IVIG) treatment. ^†𝑃<0.05 versus day of diagnosis in children with complete KD, ^∗𝑃<0.05 versus day of diagnosis in children with incomplete KD. ^§𝑃<0.05; a statistically significant difference was evident between the complete and incomplete KD groups. ^∫𝑃<0.05; a statistically significant difference was evident between the control and incomplete KD groups.